2017
DOI: 10.1159/000480336
|View full text |Cite
|
Sign up to set email alerts
|

Post-Translational Modification of Adiponectin Affects Lipid Accumulation, Proliferation and Migration of Vascular Smooth Muscle Cells

Abstract: Background/Aims: Adiponectin (Apn) is a multifunctional adipokine that circulates as several oligomeric complexes in the blood stream. Previous reports showed that several conserved lysine residues within the N-terminal collagenous domain of Apn are modified by hydroxylation and glycosylation. Here, we investigated the potential roles of post-translational modifications of Apn on the function of human vascular smooth muscle cells (VSMCs). Methods: Blood samples of 92 coronary artery disease (CAD) patients and … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(4 citation statements)
references
References 22 publications
0
4
0
Order By: Relevance
“…Adiponectin ( ADIPOQ ) is a kind of adipocytokine mainly secreted by adipose tissue. Through the action of ADIPOR1 and ADIPOR2 , it can activate the signaling pathway of AMPK and PPAR α and inhibit lipid synthesis 31 , 32 . Recently, researchers also found that some factors (such as ATGL and HSL ) can act downstream of AMPK and mediate the lipid-lowering effect of ADIPOQ 33 .…”
Section: Discussionmentioning
confidence: 99%
“…Adiponectin ( ADIPOQ ) is a kind of adipocytokine mainly secreted by adipose tissue. Through the action of ADIPOR1 and ADIPOR2 , it can activate the signaling pathway of AMPK and PPAR α and inhibit lipid synthesis 31 , 32 . Recently, researchers also found that some factors (such as ATGL and HSL ) can act downstream of AMPK and mediate the lipid-lowering effect of ADIPOQ 33 .…”
Section: Discussionmentioning
confidence: 99%
“… 141 Adiponectin also inhibits growth factor- and oxidized low-density lipoprotein-stimulated VSMC proliferation and migration. 142 , 143 Notably, an orally administered adiponectin receptor agonist decreased intimal hyperplasia in mice and inhibited PDGF-induced VSMC proliferation. 144 In models of restenosis and atherosclerosis, recombinant adiponectin decreased inflammation, oxidative stress, and apoptosis.…”
Section: Potential New Avenues For Therapeutic Modulation Of Smc Phenotype In Intimal Hyperplasiamentioning
confidence: 99%
“…It also suppresses the proliferation of HASMCs by decreasing the phosphorylation of RAF1, ERK1/2, and NF-κB as well as increasing AMPK expression [10] . Osmotin exerts the same suppressive effects of adiponectin and AdipoRon on the migration and proliferation of VSMCs [42][43][44] .…”
Section: Preventive Effects Of Osmotin On the Migration And Proliferamentioning
confidence: 97%